From May 16 to 18, 2017, the "informexusa 2017" sponsored by UBM and supported by the American Association of synthetic organic chemical manufacturers (SOCMA) will be held in Philadelphia, USA as scheduled. The exhibition is the only fine chemical professional exhibition in the United States which has been successfully held for 32 times and enjoys a high reputation in the international chemical industry. In particular, the customized synthesis business is the prominent feature of the exhibition. In 2016, more than 283 enterprises including BASF, Bayer, Evonik, Fujifilm, Honeywell, Solvay, Lonza and SK participated in the exhibition, including 41 Chinese exhibitors. This year, the exhibition merged CPHI for the first time, which will bring more cooperation opportunities.

This year, Biocompounds Pharmaceutical Inc. will participate in this grand event for the first time. In 2016, Biocompounds Pharmaceutical Inc. took a solid step in the industrialization of the company. It wholly controlled Anhui Changtai Chemical Co., Ltd. as the production and manufacturing base. The base is located in the largest provincial chemical park in Anhui. It has complete licenses, dangerous goods use qualification, complete environmental protection procedures, various reaction equipment and can complete a variety of reaction types. It has the ability to undertake the production of high-end chemicals. In addition, Biocompounds Pharmaceutical Inc. has traditionally focused more on the manufacturing of anti-tumor drugs and generic drugs. Greater breakthroughs will also be made in cGMP production in line with regulatory and market requirements. Actively seek advanced customization (CMO) for the production of high-end APIs and intermediates. Our booth number is 1156. At that time, you are welcome to visit the booth and seek common development.